News
Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.
Detailed price information for Davita Healthcare Partners Inc (DVA-N) from The Globe and Mail including charting and trades.
Akebia Therapeutics reports strong Q2 2025 earnings, driven by Vafseo’s 55% sales growth. Explore plans for expanded patient access & trial updates.
A Nebraska-based investment group recently paid $19.75 million for much of Rochester's Broadway Commons complex that houses ...
22h
TipRanks on MSNDaVita price target lowered to $154 from $157 at TD Cowen
TD Cowen lowered the firm’s price target on DaVita (DVA) to $154 from $157 and keeps a Hold rating on the shares. The firm notes the company beat ...
Learn more about whether Alignment Healthcare, Inc. or DaVita Inc. is a better investment based on AAII's A+ Investor grades, ...
Learn more about whether Addus HomeCare Corporation or DaVita Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results